Medical Devices - Enteral Access, Therapeutic Devices & Non-Invasive Therapy
Strategic Profile
The company reports commercial deployment of its ENvue Navigation Platform across 39 U.S. hospitals, recurring consumable revenue, and a February 2026 USPTO Notice of Allowance for a combined electromagnetic-navigation and distal-tip camera feeding tube. Acoustic-based therapeutic technologies, including PainShield and UroShield, utilize proprietary low-intensity surface acoustic wave technology.
Cyborg Score Rationale
While ENvue demonstrates innovative medical technology with FDA clearances and expanding hospital deployments, the company faces significant headwinds including extreme stock volatility (beta 4.29), severe short interest (56% of float), and a market cap of approximately $2-5M—typical of micro-cap biotech firms. Recent rebranding from NanoVibronix suggests strategic recalibration.
Top Insights
39 U.S. hospital deployments of ENvue Navigation Platform with recurring consumable revenue generation
Key 2026 priorities include accelerating U.S. commercial adoption, pursuing pediatric and PICC clearances, and expanding at-home ENFit syringe distribution
Stock exhibits 26.92% volatility with beta coefficient of 4.29, indicating extreme market sensitivity
Short interest stands at 470.3K shares (56% of float), up 430.2% from prior period and 2117.7% over 12 months
Named Competitors
C.R. Bard EntriStar — Feeding tube placement systems
BARD PowerPort — Central venous access devices
Teleflex Vaxel — Enteral access solutions
Recent Developments
(February 2026) USPTO Notice of Allowance for combined electromagnetic-navigation and distal-tip camera feeding tube
(January 2026) Launched over-the-counter reusable ENFit Syringes for feeding and medication delivery
(January 2026) Announced program to address patient pain and discomfort with indwelling nasogastric tubes using acoustic technology
(December 2025) Rebranded from NanoVibronix, Inc. to ENvue Medical, Inc.
Open the full interactive ENvue Medical, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.